Skip to content

Long term outcomes following a pessary placement to pregnant woman with a multiple pregnancy: 3 year follow-up of the ProTwin trial

Long term outcomes following a pessary placement to pregnant woman with a multiple pregnancy: 3 year follow-up of the ProTwin trial - ProTwinkids

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40439
Enrollment
1634
Registered
2014-04-01
Start date
2014-05-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

motorische ontwikkeling Mental and Psychomotor development

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: All patients who were randomized in the ProTwin study (n

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The mean scores on the Bayley (mental and motor) scales. The mean scores of the Bayley in the general population is 100. A mean score below 92,5 (0,5 Standard Deviation, SD) is defined as clinically relevant. A sample size of 86 in each group (n=172) will have 90% power to detect a difference in means of 7,5 (the difference between a Group 1 mean of 100 and a Group 2 mean of 92,5 assuming that the common standard deviation is 15 using a two group t-test with a 0,05 two-sided significance level ß of 0.20. This means that a total of 69% should be reached in the follow-up and only 31% can be missed due to loss to follow-up or other reasons.

Secondary

MeasureTime frame
The scores in the ASQ, CBCL, general health status and maternal fertility questionnaires will be evaluated in secundary analyses. Comparison of the pessary group with the no-pessary group will be performed. For the ASQ questionnaire an abnormal score is a score of *2SD below the expected mean of a reference population. For the CBCL questionnaire for each scale, a strandardized T-score will be calculated. An abnormal T-score is a score at the >97 percentile. Scores on the general assessment questionnaire will be used for correction if there are relevant differences on the baseline characteristics. Univariate regression analysis will be performed to test the predictive value of a multiple antepartum variables on the neurodevelopmental and health related outcomes. Mortality Besides developmental outcomes we will register all children who died between the short term and long term follow-up. The possible difference in percentage will be tested for significance using Chi-square test.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)